GLI said Uzbekistan was entering its operational phase, with four licences issued across two operators. It also said parts of the technical framework were still being established and discussions with NAPP were continuing.
This evolving position makes direct regulatory confirmation important. Operators and suppliers should verify the latest standards, accepted report formats and testing scope with NAPP instead of treating the laboratory listing as blanket approval. They should also determine who will answer regulator queries and maintain certification following launch.
Recognition of an accepted laboratory is nevertheless an important piece of market infrastructure. Independent testing gives regulators evidence about system integrity while providing applicants with a more predictable approval pathway. Other licensing regimes similarly rely on independent laboratory validation as part of their controls.
For Uzbekistan, the immediate significance is practical: suppliers have a stated route for presenting technical evidence, while operators can include recognised certification in their market-entry planning. The listing removes one area of uncertainty, but a successful launch will still depend on compliance with NAPP’s developing technical rules and the complete licensing framework.